Life Science

The orally active metabolite of the non-sedating antihistamine loratadine an antagonist of the histamine H1 receptor (Ki = 0.97 nM).

The orally active metabolite of the non-sedating antihistamine loratadine an antagonist of the histamine H1 receptor (Ki = 0.97 nM).

The orally active metabolite of the non-sedating antihistamine loratadine an antagonist of the histamine H1 receptor (Ki = 0.97 nM).

The primary metabolite of the tricyclic antidepressant doxepin.

The primary metabolite of the tricyclic antidepressant doxepin.

The primary metabolite of the tricyclic antidepressant doxepin.

A major urinary metabolite of the selective serotonin reuptake inhibitor paroxetine may be used as a control in LC/MS or GC/MS paroxetine testing applications.

A major urinary metabolite of the selective serotonin reuptake inhibitor paroxetine may be used as a control in LC/MS or GC/MS paroxetine testing applications.

A major urinary metabolite of the selective serotonin reuptake inhibitor paroxetine may be used as a control in LC/MS or GC/MS paroxetine testing applications.

A synthetic version of the endogenous antidiuretic hormone arginine vasopressin acts as an agonist at human vasopressin V1a, V1b, and V2 receptors with Ki values of 62.4, 5.8, and 23.3 nM, respectively.

A synthetic version of the endogenous antidiuretic hormone arginine vasopressin acts as an agonist at human vasopressin V1a, V1b, and V2 receptors with Ki values of 62.4, 5.8, and 23.3 nM, respectively.

A synthetic version of the endogenous antidiuretic hormone arginine vasopressin acts as an agonist at human vasopressin V1a, V1b, and V2 receptors with Ki values of 62.4, 5.8, and 23.3 nM, respectively.